SCHEMBL30936588

SCHEMBL30936588

CN(c1ccccc1NS(=O)(=O)c1ccc(S(=O)(=O)N(C)C)cc1)C1CCC(C)(C)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 1/20 0.43
HTR6 P50406 2/20 0.39
LMNA P02545 3/20 0.39
POLB P06746 2/20 0.39
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
KDM4E B2RXH2 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
USP2 O75604 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NOD2 Q9HC29 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936675 0.93 MCOLN2 (0.41) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL31720595 0.90 MCOLN2 (0.42) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL31720603 0.89 MCOLN2 (0.49) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL31720602 0.88 LMNA (0.49) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL31720818 0.87 LMNA (0.51) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL31720764 0.87 MCOLN2 (0.38) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL30936647 0.86 MCOLN2 (0.44) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL31720775 0.86 MCOLN2 (0.41) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL30936702 0.85 MCOLN2 (0.43) MCOLN2HTR6LMNAPOLBALDH1A1
SCHEMBL31720805 0.85 MCOLN2 (0.43) MCOLN2HTR6LMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 MCOLN2 19/4885HTR6 304/4885LMNA 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.